Email Newsletters

Life Sciences

ACT Secures $35M In Stock Deal

Marlborough-based Advanced Cell Technology announced that it has made a $35-million deal with an investor that will...

Incubator Grant To Benefit Worcester

The National Science Foundation (NSF) has tapped Worcester as one of three cities to share a $2.65-...

Pall Corp. To Open Center In Westborough

New-York-based Pall Corp. has announced plans for a "Life Sciences Center of Excellence" in Westborough.Operations and employees...

Boston Scientific Acquires Minn. Firm

Boston Scientific of Natick has agreed to buy a Minnesota company that makes catheters to treat chronically...
ADVERTISEMENT

Report Says Biopharma Jobs In Mass. Hit New High In 2011

Employment in the biopharma industry across Massachusetts, where the average salary tops $113,000, grew 1 percent last...

Generex Addresses Unusual Trading Of Shares

Generex Biotechnology Corp., the Toronto parent company of Worcester-based Antigen Express Inc., has responded to the unusually...

Genzyme MS Drug Gets FDA Approval

The U.S. Food and Drug Administration (FDA) has approved a Genzyme drug for patients with relapsing forms...

UMass Med School Central In Human Genome Mapping

For the past nine years, researchers from the University of Massachusetts Medical School and other institutions around...
ADVERTISEMENT

Sunovion Acquires San Diego Biopharma Company

Sunovion Pharmaceuticals Inc. of Marlborough has signed an agreement to acquire Elevation Pharmaceuticals Inc. The privately-held Elevation is...

IPG Expands Laser Systems Offerings With Acquisition

Oxford-based IPG Photonics Corp. has announced the acquisition of a New Hampshire laser micromachining supplier. IPG said it...
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA